| Literature DB >> 32529114 |
Sergio Machado1,2, Alberto Souza Sá Filho3,4, Carlos Campos5, Carolina Cavalcante de Paula6, Fabyana Bernardes1,2, Eric Murillo-Rodriguez7,8, Geraldo A Maranhão Neto9, Eduardo Lattari1,2.
Abstract
To evaluate the acute effects of ingestion of 500 mg of caffeine in addition to aerobic exercise on the optimization of cognitive attention tasks and simple reaction time. Twenty men were randomly divided into two groups, caffeine (CAF) and placebo (PLA), and underwent cardiopulmonary exercise testing and cognitive testing (D2SLK, D2GZ, D2F% and TRS). Then, both ingested 500 mg of caffeine or placebo (double blind), and after 60 min performed a 30-minute continuous exercise session at 70 % VO2Max. Cognitive tests were repeated immediately after exercise, and after 30 min. D2SLK, D2GZ, D2F% and TRS scores were compared by repeated measures ANOVA. The magnitude of the effect was established, and it was considered meaningful p = 0.05. CAF is able to alter D2SLK and also reduce D2F% (0.001 - moderate effect, 0.82) and improve the task after 30 min of exercise (p = 0.014 - moderate effect 0.95). The TRS showed significant gains for the CAF group compared to PLA (0.000 - high effect 1.76). Caffeine induces significant effects in attention and reaction time domains independent of the effect of aerobic exercise.Entities:
Keywords: Aerobic exercise; Caffeine; Cognitive performance; VO2Max
Year: 2020 PMID: 32529114 PMCID: PMC7283292 DOI: 10.1016/j.ibror.2020.01.002
Source DB: PubMed Journal: IBRO Rep ISSN: 2451-8301
Sample Characteristics.
| Characteristics | Group CAF | Group PLA |
|---|---|---|
| (mean ± standard deviation) | ||
| Age (years) | 28.3 ± 5.9 | 30.9 ± 7.2 |
| Body mass (kg) | 73.5 ± 6.2 | 78.3 ± 8.3 |
| Height (cm) | 175.7 ± 5.9 | 178.2 ± 7.2 |
| Percent fat (%) | 17 ± 4.2 | 13 ± 4.4 |
Sample characteristic data presented mean ± standard deviation, p > 0.05.
Fig. 1Experimental approach.
Fig. 2Results of D2 performance over time for participants with caffeine intake plus aerobic exercise (CAF group) and participants with placebo plus aerobic exercise (PLA group). A. The total number of confusion and elimination errors (D2-F%;). B. Quantitative measurement of working speed (D2-GZ) C. Measurement that reflects the attention span the number of correct answers minus confusion errors (D2-SKL). Values are expressed as mean ± SD (n = 20) for groups ingesting 500 mg of caffeine (CAF) or 500 mg of placebo (PLA) P ≤ 0.05 * CAF vs PLA.
Fig. 3SRT performance results over time. Values are expressed as mean ± SD (n = 20) for groups that ingested 500 mg of caffeine (CAF) or 500 mg of placebo (PLA) P ≤ 0.05; * CAF vs PLA.
Standardized mean and SD for the caffeine and placebo group at baseline, after caffeine/placebo intake and after exercise.
| Test | CAF group | PLA group | ||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | AC | AE | Baseline | AC | AE | |||
| D2-SKL | 103.7 | 105.1 | 112.5 | 1.33 | 103.1 | 102.9 | 103.2 | 0.01 |
| (6.6) | (4.6) | (4.7) | (5.8) | (5.9) | (5.9) | |||
| D2-GZ | 100.3 | 101.1 | 108.5 | 1.49 | 98.0 | 97.5 | 98.2 | 0.04 |
| (5.5) | (4.5) | (4.6) | (5.1) | (5.4) | (5.2) | |||
| D2-F% | 98.1 | 97.2 | 92.6 | 0.86 | 96.2 | 96.1 | 96.9 | 0.13 |
| (6.4) | (5.4) | (2.5) | (5.5) | (4.5) | (4.0) | |||
| SRT | 222.5 | 212.3 | 188.6 | 1.76 | 227.2 | 224.9 | 217.8 | 0.32 |
| (19.2) | (14.0) | (4.3) | (15.2) | (9.3) | (4.1) | |||
CAF: caffeine group; PLA: placebo group; AC: 1 h after caffeine or placebo intake; AE: after aerobic exercise.